03. September 2010  |  Home
Our Concept

The endpoint of drug development is highly regulated in order to improve safety and efficacy of the drug product. Beyond the scientific and technical risks the structure and quality of integration between the involved disciplines have the highest impact on the performance of the drug development process and thus determines the entrepreneurial risk.

We focus on improving performance of integrated drug development.
Services

We offer full service in

  • Project Management
  • Nonclinical Development
  • Clinical Development Phase I-IV
  • Medical Writing
  • Quality Assessment
  • Regulatory (EMEA, FDA)

read more >
Partners

CDRD Berolina AB has been operating within the BDD/CDRD Group for two decades and has long lasting collaborations within its network of excellent international specialists. This allows us to meet the specific needs of 

  • Start up's and Small Caps
  • Generic Companies
  • Large Pharmaceutical Companies
  • Venture Companies and Analysts

read more >
Integrated Drug Development

We offer special services for

  • Project Potential Assessment
  • Structure for Interdisciplinary Communication
  • Risk Management
  • Development Performance Assessment
  • Communication Plan for External Partners

read more >
What are you looking for?
search now >
© 2009 BDD/CDRD | Disclaimer | Imprint
CDRD Berolina AB